This information argues in favor of amyloid formation for mutations affecting leucine 509 residue, and we think that patients with p.Leu509Arg mutation of TGFBI should not be classified as EBMD, but rather as having a lattice form of corneal dystrophy. This evidence concerns the gene TGFBI and corneal dystrophy.